ArticlePloS one2013

Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response.

Patricia M Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.